A large randomized clinical trial is necessary to establish the role of camrelizumab in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Ravindran, Nishal, Thuluvath, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607078/
https://www.ncbi.nlm.nih.gov/pubmed/33178785
http://dx.doi.org/10.21037/atm-2020-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607078/
https://www.ncbi.nlm.nih.gov/pubmed/33178785
http://dx.doi.org/10.21037/atm-2020-71

Ejemplares similares